This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ARTHUR C. REINIGER, M.D.; GEORGE BIALKIN, M.D.; JAMES Q. GANT, M.D.; MANNING J. ROSNICK, M.D.; ANTHONY J. MONTEBOVI, M.S.; ALFRED HALPERN, Ph.D.

AMA Arch Otolaryngol. 1959;69(3):293-302.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The medical literature contains many references^1-5 to the dangers of excessive or impacted cerumen, yet there is little to offer pharmaceutically to either physician or patient for its safe, convenient, and effective removal. Many of the preparations recommended for this purpose have been abandoned when it was found that they were not effective for the intended purpose, or, in some instances, introduced secondary problems which interfered with their efficacy. This report describes the development and study of a new cerumenolytic which has been found to be a safe and effective agent for the removal of excessive or impacted cerumen.

In 1947, Senturia and associates⁶ reported that many formulations which claimed to be efficient cerumenolytic agents were, in effect, worthless. According to this group's findings, irrigation with distilled water and hydrogen peroxide remained the best means of disintegrating ear wax. However, since 1947, there have been many advances made . . . [Full Text PDF of this Article]

Author Affiliations
New York; Washington, D. C.; Coral Gables, Fla.; Brooklyn; New York

Chief, Department of Otolaryngology, The Stuyvesant Polyclinic, Lecturer, New York Polyclinic Medical School, N. Y. (Dr. Reiniger); Adjunct Pediatrician, Bronx Hospital (Dr. Bialkin); Assistant Professor of Dermatology, George Washington University, and Chief, Department of Dermatology, V. A. Regional Office (Dr. Gant); Active Attending, Department of Medicine, University of Miami School of Medicine (Dr. Rosnick); Professor, Department of Chemistry, College of Pharmacy, St. John's University (Mr. MonteBovi); Director, Department of Experimental Therapy, The Stuyvesant Polyclinic (Dr. Halpern).

Footnotes
Submitted for publication June 2, 1958.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?